Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers.
10.1038/s41368-021-00145-1
- Author:
Yi LI
1
;
Wei GUO
2
;
Xiuqin LI
3
;
Jianguo ZHANG
4
;
Moyi SUN
5
;
Zhangui TANG
6
;
Wei RAN
7
;
Kai YANG
8
;
Guilin HUANG
9
;
Longjiang LI
10
Author Information
1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
2. Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
3. Department of Obstetrics and Gynecology, Shengjing Hospital China Medical University, Shenyang, China.
4. Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking University, Beijing, China.
5. Department of Oral and Maxillofacial Surgery, The Third Affiliated Hospital, Air Force Medical University, Xi'an, China.
6. Department of Oral and Maxillofacial Surgery, Xiangya School of Stomatology, Central South University, Changsha, China.
7. Department of Oral and Maxillofacial Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
8. Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
9. Department of Oral and Maxillofacial Surgery, Stomatological Hospital, Zunyi Medical University, Zunyi, China.
10. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China. muzili63@163.com.
- Publication Type:Research Support, Non-U.S. Gov't
- MeSH:
Adenoviridae/genetics*;
Consensus;
Head and Neck Neoplasms/therapy*;
Humans;
Tumor Suppressor Protein p53/genetics*
- From:
International Journal of Oral Science
2021;13(1):38-38
- CountryChina
- Language:English
